Certified by Founder Lodge
Sift Biosciences
United States - San Carlos, CA
START UP
1 Disclosed Funding Rounds $3,700,000
0 Participating Investments
-
Founded date
2024
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Using AI and high-throughput T-cell screening, Sift is developing a new class of T-cell modulators to treat cancers and autoimmune diseases.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 19 ,2026 | Pre-Seed | $3,700,000 |
FreeFlow Ventures
Lifespan Vision Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Combat Medical Ltd | $3,472,639 | (Mar 13, 2026)
Ezra(2) | $8,000,000 | (Mar 13, 2026)
Arycs Technologies | $24,000,000 | (Mar 13, 2026)
Mantis Space | $10,000,000 | (Mar 13, 2026)
Freestyle | $10,000,000 | (Mar 13, 2026)
